INTRODUCTION
Ketamine hydrochloride is 2-0-chlorophenyl-2 methylamino-cyclohexane and has been used since] 965 to produce a state called" Dissociative Anaesthesia". Numerous workers have studied the electroencephalographic effects of the drug in animals and humans and demonstrated differing effects on different parts of the brain. Hunter (1972) describes the effects as depression of the neocortex and some sub-cortical areas such as the thalamus. The drug activates the limbic system, particularly the hippocampus and does not appear to affect the reticular activating system. One of its peculiarities is that it produces delta activity in somatosensory areas of the EEG, but the auditory and visual areas are not affected. It is the property of the drug to affect one part of the brain and not others that gives rise to the title" Dissociative Anaesthesia" . Chen, Ensor and Bohner (1966) showed that ketamine prevented both electrical and pentylenetetrazol induced seizures in mice and other workers have commented on the drug's anticonvulsant activity in convulsions due to epilepsy and tetanus (Anaesthetic Department Report 1969 , Corssen, Groves, Gomez and AlIen 1969 , Phillips, Seruvatu, Rika and Tirikula 1970 . However, there have been no cases described where ketamine was deliberately given as treatment for epileptic convulsions. Wyant (1971) , Walker (1H72) and Thompson (1972) have described cases where ketamine caused convulsions and Winters (1972) has stated that the drug is contraindicated in the treatment of epilepsy.
CASE REPORTS
Case 1 L.A., a:2 year old child with mental retardation and grand mal epilepsy, was regularly brought into hospital with severe grand mal convulsions, in spite of regular anticonvulsant therapy. Her treatment was made more difficult by the relative inaccessibility of her veins and her convulsions not responding to barbiturates, diphenylhydantoin and paraldehyde. The dosage of diazepam which would stop the convulsions was increasing rapidly. In April 1971 she had required 70 mg (4· 7 mg/kg) of diazepam intravenously through a cutdown to stop the convulsions.
It was decided that on her next admission she would be given a general anaesthetic to control the convulsions, and in view of the difficulties with venepuncture and the difficulties in giving an inhalational anaesthetic it was decided to try intramuscular ketamine. In May 1971 she ~was brought into hospital with grand mal convulsions of 45 minutes' duration. She had begun convulsing during a meal and her oropharynx was full of food. She was given ketamine (300 mg (20 mg/kg) intramuscularly and her oropharynx was cleared. After three minutes the fitting ceased and she vomited a small quantity of food. Laryngoscopy revealed no trace of food in the oropharynx or larynx. After 20 minutes she turned over in bed and removed the oropharyngeal airway and then slept removed the oropharynx airway and then slept for twelve hours and was discharged from hospital in the morning. Seven weeks later she was readmitted with severe grand mal convulsions of 20 minutes' duration and was given 200 mg of ketamine intramuscularly and the fitting ceased in seven minutes. On many subsequent admissions she was given 300 mg of ketamine intramuscularly and the convulsions ceased within four minutes and only on one occasion was a second dose necessary. Because of the severity of her convulsions and the difficulty in controlling them, her parents had been unwilling to travel far from the hospital and her mother was given a bottle of ketamine and an instruction card to give the doctor in the nearest Emergency Accident department should the child begin fitting while they were away, with the happy result that the family's life stopped revolving around the child's fits. The treatment has been continued to the present time with no evidence of tolerance to the drug.
Case 2
L.D., a 17 month old boy, with a history of grand mal epilepsy from age three months, had a history of eight admissions over a six-month period with persistent grand mal convulsions, on four occasions associated with a febrile illness. He was receiving regular anticonvulsant therapy. On three occasions the fits became prolonged and did not respond to conventional anticonvulsants. On two occasions the convulsions ceased within three minutes of 50 mg of ketamine intramuscularly (5 mg per kg). On one occasion the convulsions were stopped by 20 mg of ketamine intramuscularly but a second dose was needed one hour later. (1972) has stated that ketamine is contraindicated in epilepsy because of its central stimulatory effects. He says that administration of ketamine to a patient having an epileptic fit could push the patient into status epilepticus. He cites an unpublished study showing repeated administration of ketamine to rats will induce spontaneous epileptiform patterns in the EEG. Allado et al. (1973) described nine epileptic patients with implanted thalamic electrodes of whom six showed seizure activity on the EEG after 2-4 mg ketamine intravenously. Of these, three showed tonic-clonic motor activity. They suggested that abnormal movements associated with ketamine may be due to thalamic and limbic seizure activity not seen on surface EEGs but detectable by implanted leads. These three cases are the only cases where EEG seizure activity has been correlated with physical convulsions.
DISCUSSION

Winters
Convulsions due to ketamine have been described and the incidence may be gauged from Table 1 . A further case has been described in a 26-year-old woman (Thompson 1972) . There have been, however, no other reported cases of ketamine causing convulsions in epileptics or making epilepsy worse. Shapiro, Whyte and Harris (1972) have demonstrated a gross rise in intracranial pressure in patients with a raised cerebrospinal fluid pressure due to intracranial obstruction, and Gibbs (1972) has confirmed this and suggested that ketamine is contraindicated in states of raised cerebrospinal fluid pressure, although his findings suggested there was no significant change in cerebral perfusion. Although cerebrospinal fluid pressure is raised during epileptic convulsions, the pressure rise is not due to intracranial obstruction, and until we are able to measure the cerebrospinal fluid pressure changes in one of these two cases we have chosen to ignore this as a contraindication to the use of the drug. The variation in effective dosage in the two cases can be explained by the fact that the second patient has always received other anticonvulsants before ketamine was tried, and the first patient received ketamine as the only treatment. The higher than normal dose was given to the first patient because mentally retarded children require higher doses of ketamine than normal.
Ketamine in the two cases described showed five advantages over other anticonvulsants.
(a) Potent and successful where other agents had failed. (b) Rapid onset of action by intramuscular injection, making venepuncture unnecessary. (c) Ease of supporting airway. (d) Protective reflexes were preserved.
(e) No tolerance demonstrated. We therefore conclude that ketamine is worthy of use in difficult cases of convulsions, in spite of evidence of disadvantages to its use. It must be remembered, however, that ketamine should only be used by someone skilled in the maintenance of an airway and the support of ventilation.
